Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.08EUR
2.27 MEUR
174.53 MEUR
55.10 M
About Vanda Pharmaceuticals Inc.
Sector
CEO
Mihael Hristos Polymeropoulos
Headquarters
Washington
Website
Employees (FY)
203
Founded
2002
FIGI
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VM4 is 5.10 EUR — it has decreased by 6.42% in the past 24 hours. Watch VANDA PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange VANDA PHARMACEUTICALS INC stocks are traded under the ticker VM4.
VM4 stock has fallen by 8.93% compared to the previous week, the month change is a 11.35% rise, over the last year VANDA PHARMACEUTICALS INC has showed a 22.60% increase.
We've gathered analysts' opinions on VANDA PHARMACEUTICALS INC future price: according to them, VM4 price has a max estimate of 4.86 EUR and a min estimate of 4.86 EUR. Watch VM4 chart and read a more detailed VANDA PHARMACEUTICALS INC stock forecast: see what analysts think of VANDA PHARMACEUTICALS INC and suggest that you do with its stocks.
VM4 stock is 6.86% volatile and has beta coefficient of 0.12. Track VANDA PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is VANDA PHARMACEUTICALS INC there?
Today VANDA PHARMACEUTICALS INC has the market capitalization of 307.21 M, it has decreased by 5.61% over the last week.
Yes, you can track VANDA PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
VANDA PHARMACEUTICALS INC is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
VM4 earnings for the last quarter are −0.06 EUR per share, whereas the estimation was 0.05 EUR resulting in a −240.00% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about VANDA PHARMACEUTICALS INC earnings.
VANDA PHARMACEUTICALS INC revenue for the last quarter amounts to 43.99 M EUR, despite the estimated figure of 44.95 M EUR. In the next quarter, revenue is expected to reach 44.38 M EUR.
VM4 net income for the last quarter is −3.84 M EUR, while the quarter before that showed −2.17 M EUR of net income which accounts for −76.71% change. Track more VANDA PHARMACEUTICALS INC financial stats to get the full picture.
No, VM4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 30, 2024, the company has 203.00 employees. See our rating of the largest employees — is VANDA PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VANDA PHARMACEUTICALS INC EBITDA is −19.12 M EUR, and current EBITDA margin is −5.68%. See more stats in VANDA PHARMACEUTICALS INC financial statements.
Like other stocks, VM4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VANDA PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.